Objective To estimate household cost of illness (COI) for children with severe pneumonia in Bangladesh.
Design An incidence-based COI study was performed for one episode of childhood severe pneumonia from a household perspective. Face-to-face interviews collected data on socioeconomic, resource use and cost from caregivers. A micro-costing bottom-up approach was applied to calculate medical, non-medical and time costs. Multiple regression analysis was applied to explore the factors associated with COI. Sensitivity analysis explored the robustness of cost parameters.
Setting Four urban and rural study sites from two districts in Bangladesh.
Patients Children aged 2–59 months with severe pneumonia.
Results 1472 children with severe pneumonia were enrolled between November 2015 and March 2019. The mean age of children was 12 months (SD ±10.2) and 64% were male. The mean household cost per episode was US$147 (95% CI 141.1 to 152.7). Indirect costs were the main cost drivers (65%, US$96). Household costs for the poorest income quintile were lower in absolute terms, but formed a higher proportion of monthly income. COI was significantly higher if treatment was received from urban health facilities compared with rural health facilities (difference US$84.9, 95% CI 73.3 to 96.3). Child age, household income, healthcare facility and hospital length of stay (LoS) were significant predictors of household COI. Costs were most sensitive to hospital LoS and productivity loss.
Conclusions Severe pneumonia in young children is associated with high household economic burden and cost varies significantly across socioeconomic parameters. Management strategies with improved accessibility are needed particularly for the poor to make treatment affordable in order to reduce household economic burden.
- health services research
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
What is already known on this topic?
Pneumonia is the leading cause of death among under-5 children worldwide.
Seeking care for pneumonia is poor in resource-poor countries and involves substantial costs for households, particularly for lower socioeconomic groups.
Previous studies, largely from small urban and small-scaled samples, estimated the cost of management from US$42 to US$5977 per episode of severe pneumonia.
What this study adds?
The study estimated the mean household cost (US$147) with a large sample from rural and urban areas in Bangladesh using a micro-costing approach.
The study identified the common resources used and calculated the indirect costs to unpaid caregivers (US$95), along with direct medical and non-medical costs.
The study compared cost burden according to socioeconomic group and facility location, assessed the predictors of cost and determined cost-sensitive parameters.
Pneumonia is the leading cause of death among under-5 children worldwide, with an estimated 0.8 million deaths in 2017.1 2 Mortality is disproportionately higher in low-income and middle-income countries (LMICs), where 95%–99% of pneumonia-specific under-5 deaths occur.3 The estimated incidence of clinical pneumonia among under-5 children in LMICs is 0.28 episodes per child-year and is predominant in South Asia and sub-Saharan Africa.4 5 A total of 12% of pneumonia episodes progressed to severe pneumonia, which relies on hospitalisation with supportive treatment and careful monitoring.5–8 In Bangladesh, pneumonia accounts for 28% of under-5 mortality and about 40% of paediatric hospital admissions,9 10 while only 42% of parents report seeking care from trained providers for a child with pneumonia symptoms.11
Childhood pneumonia imposes high economic burden on households, healthcare systems and society as a whole.12 13 The high prevalence among lower socioeconomic groups in Bangladesh is a significant concern because a substantial amount of costs are borne by households when seeking care from any healthcare facility.14–17 In a systematic analysis, Zhang et al12 reported the costs of pneumonia management, where the cost of inpatient care ranged from US$42 to US$5977 (2019 inflation-adjusted). Three studies were conducted in Bangladesh but were small-scaled, limited in terms of the scope of costs included and were largely conducted in urban areas.18–20 In addition, evidence from the review reveals methodological limitations with lack of detailed information on resource use, particularly from the household’s perspective.12
Detailed cost estimation based on rigorous methodologies is crucial to accurately inform policy to efficiently allocate scarce resources. In this context, the current study intended to estimate the household cost of illness (COI) per episode of childhood severe pneumonia, to assess cost variation across rural and urban groups, and to determine the associated predictors in the context of Bangladesh.
Materials and methods
This study was nested in an effectiveness trial that compared daycare management approach (DCA) with usual care for treatment of childhood severe pneumonia. The trial was conducted by the International Centre for Diarrhoeal Disease Research, Bangladesh between November 2015 and March 2019 and covered an urban district (Dhaka) and a rural district (Kishoreganj). In this effectiveness trial, severe pneumonia in children aged 2–59 months was defined following the WHO criteria as ‘cough or difficulty in breathing, plus at least one of the following: central cyanosis or oxygen saturation <90% on pulse oximetry, severe respiratory distress (e.g., grunting, very severe chest indrawing), signs of pneumonia with a general danger sign: inability to breastfeed or drink, lethargy or unconscious, convulsions’.8
Study sites and sample
A total of 32 public or non-governmental organisation-run clinics (clusters) were randomly selected from the trial sites and allocated equally to either DCA or usual care management. For usual care (control clusters), enrolled children were referred directly to the local hospitals after initial assessment. The referral patterns in the control arm of the trial were unchanged from usual practice, with trial setting having no influence on participant behaviour or referral patterns. All enrolled children in the control clusters (n=16) were included for household COI estimation in the study.
Method of measuring cost
This study adopted a household perspective to estimate incidence-based COI for one episode of childhood severe pneumonia. Household costs include all illness-related out-of-pocket (OOP) costs and time cost/wage loss of patients and caregivers. The main cost components included direct medical, direct non-medical and indirect costs.
Identification of resources
A bottom-up micro-costing approach was applied to collect all relevant economic data related to resource use associated with pneumonia treatment.21 This involved identification of all resources used, with the quantity and unit price of each item. Medical care expenses such as physician consultation fees, medicines, diagnostic tests and bed charges were considered as direct medical costs. Non-medical expenses such as transportation, food and lodging were considered as direct non-medical costs21 (online supplemental material 1 table S1).
Indirect costs refer to income and/or productivity loss incurred due to illness.22 The human capital approach was applied to estimate lost wages/productivity, using self-reported wage rate/direct income loss for paid workers as per earlier studies and the minimum hourly wage rate for unpaid workers in Bangladesh.17 18 23 24
Data collection tool
Existing literature and prior experience of the research team were used to design the COI questionnaire.12 15 16 18 23 Data collection tools (household questionnaire) were piloted in both urban and rural areas to identify questions/variables that needed to be added or excluded and to identify potential barriers (online supplemental material 2). All of the identified challenges were resolved before final data collection. Trained and experienced interviewers collected data in face-to-face interviews with the parent/caregiver. Interviews were conducted on the day of trial enrolment and on the day of hospital discharge. Data on demographics, socioeconomic characteristics, resource use (quantity and expenses), waiting time, caregivers’ time, wage and/or productivity loss, and household coping strategies to manage expenses were collected. To reduce recall bias and minimise reporting errors, the interviewee was asked to check items, quantities and prices from purchase receipts or prescriptions. Informed written consent was taken prior to the start of each interview.
Data were checked to identify potential errors and then verified to conserve data accuracy. Cost data were skewed; therefore, we presented median and IQR along with mean and SD in US dollars, in 2019 price year. Due to skewness, log-linear models were adopted to explore the predictors of household costs.25 Household cost was considered as the dependent variable and logged-linear regression models were constructed using demographic and socioeconomic variables.12 Variables were added to the regression model that had a correlation coefficient of >0.15 with the dependent variable. A multivariate logged linear regression model was used to adjust for potential confounding factors; a low mean value of variance inflation factor confirms that there was no notable multicollinearity in the model.
One-way sensitivity analysis was undertaken to test the robustness of the results. We tested the effect of changes of ±20% in each cost parameter value for both direct and indirect costs and ±1 day in average length of stay (LoS) to identify the most cost-sensitive parameters.18 24 Mean imputation method was used to replace any missing data.26 All analyses were undertaken first as complete case and then using mean imputation. Imputed results are presented, although given the low level of missing data (2%) complete case results were very similar (online supplemental material 3 table S2 and S3). Statistical significance level was considered as p value less than 0.05 with 95% CI. All analyses were performed using STATA V.16.1 statistical software.
Written informed consent was taken from the parents/guardians of the recruited children prior to data collection.
Background characteristics of the study participants
Background characteristics of the children are described in table 1 by urban and rural distribution. A total of 1472 children were enrolled, of whom 65% were male, with a mean age of 12.2 (SD ±10.2) months. Age and gender distributions were similar for the urban and rural groups. Overall, age was skewed, with 65% of children aged up to 1 year. The sample revealed skewness towards the wealthier quintiles, particularly in urban areas (table 1). The average monthly household income was US$277 (SD ±275), with higher income for urban residents. The average LoS in hospital was 5.0 days.
Resources used, distribution of average COI by type of facility and average household costs
Table 2 shows the resources used and the average costs by type of facility and the distribution of household costs per episode for each parameter. The most commonly used resources were medicines, admission fees, medical consumables and transportation. The mean household cost per episode was US$147 (SD ±114.6) (median US$116, IQR 95.3), comprising 35% direct costs (US$51) and 65% (US$96) indirect costs. The mean cost per episode was highest for households using private facilities (US$268) and lowest for those using upazila health complex (US$90). Overall, the mean cost was significantly higher among households that received treatment from urban health facilities (US$177) compared with rural health facilities (US$92) (online supplemental material 4 figure S1).
Distribution of household cost per episode of severe childhood pneumonia across income quintiles
Figure 1 shows the mean household COI per episode and its distribution across income quintiles. Overall, the costs were higher for higher income quintiles (p<0.001). The direct cost was US$24 for the poorest households, while it was about three times higher for the richest households. Similarly, the indirect cost was also higher (US$126) for the richest households.
We assessed COI as a percentage of household monthly income. OOP expenditure differed significantly across income groups and facility location (p<0.001). Although the mean household cost per episode was higher for the richest quintiles, the poorest households spent more as a percentage of their monthly income compared with the richest households (urban: 43% vs 13%; rural: 20% vs 5%) (online supplemental material 5 figure S2).
Households’ coping strategies for managing costs
Most households financed their child’s treatment expenses from regular income (67%), while 37% of the households required spending from their savings and 19% reported borrowing to cover treatment costs. Regular income was the primary cost management strategy for both rural and urban residents (77% vs 62%), while urban households borrowed more than rural households (23% vs 10%) (supplemental material 6 figure S3).
Predictors of household costs per episode of childhood severe pneumonia
Bivariate and multivariate logged linear regression models found that LoS, income quintile, type of healthcare facility and age of the child were significant predictors of household COI for childhood severe pneumonia. For instance, an additional day in the hospital was associated with a 13% increase in log-transformed total cost per household (p<0.001), and being in the richest income quintile was associated with a 24% increase relative to the poorest quintile (p<0.001). Children from urban areas had higher COI compared with children from rural areas (33%, p<0.001) (table 3).
Household mean COI per episode was most sensitive to changes in average LoS and caregivers’ income loss. A 1-day reduction in hospital LoS reduced household COI by 25%, and a 20% increase in caregivers’ time cost increased COI by 13% (figure 2).
In general, COI studies are used to define the economic burden of disease and to recommend policy for decision-making in order to efficiently allocate healthcare resources. The current study estimates household COI covering both direct and indirect costs at a highly detailed level. We also compared the distribution of costs across facility type and location, determined the predictors of cost and performed a sensitivity analysis. Overall, our study provides a more detailed characterisation that indicates management of childhood severe pneumonia poses a substantial economic burden to households, particularly to the poorest socioeconomic groups and if treatment is provided by urban hospitals.
It is evident that household costs pose a substantial burden particularly to inpatient care.12 Findings from other LMICs reported household cost per patient ranged from US$21 to US$326 (2019 inflation-adjusted), although most studies reported only direct cost and therefore underestimated the total cost burden.18 19 27–30 Our estimated per patient household costs are comparatively lower than the reported costs (2019 inflation-adjusted) for other LMICs, such as Kenya (US$260),31 India (US$212)32 and Jordan (US$616),33 but higher compared with Pakistan (US$103).34 The cross-country cost variation may be explained by differences in the health system, in particular the contribution of OOP payment to health expenditure, as well as by methodological variation between studies in cost estimation, disease severity and type of facility providing care (community management, outpatient care and inpatient care). Our study also demonstrates that the cost of medicine constituted the major proportion of direct inpatient care costs. Consistent with our findings, several previous studies conducted in other LMICs also reported similar costs, in which the cost of medications was the major cost driver of the total OOP expense from households.23 27 30 31
High OOP expenditure can be largely attributed to the fact that there is a lack of public inpatient care facilities in Bangladesh, many with insufficient supply of required resources such as personnel, medicines and other medical consumables to treat children optimally. Health insurance would probably be the better solution to lower OOP cost, but these are limited in most LMICs including Bangladesh.20 35 Earlier studies also reported unofficial or informal fees to gain access to public healthcare facilities, which increase the total cost of treatment.19 30
Our findings demonstrate that OOP expenditure is a substantial burden particularly for poor socioeconomic groups, where health expenditure is comparatively lower in absolute terms compared with richer groups but higher in relative terms, as a proportion of monthly household income. OOP expenditure per episode was about one-third of the monthly household income of the poorest group, which would classify these households as facing catastrophic health expenditure (over 40% of the household income net of subsistence expenditure).36 OOP expenditure in this study was mainly sourced from regular income, followed by savings and borrowing. Likewise, other studies conducted in similar settings, including Bangladesh, revealed use of income, savings and borrowing with interest to manage treatment cost.20 31
In Bangladesh, catastrophic healthcare expenditure pushes about six million people towards poverty.37 To mitigate this challenge, moving towards achieving universal health coverage, Bangladesh has health financing strategies to create health insurance schemes. For instance, a health insurance scheme for populations below the poverty line has been piloted in three subdistricts.37 Findings from this study underline the importance of effective and affordable health insurance for vulnerable families to protect children from pneumonia-specific mortality.
Our findings show that indirect costs are significantly higher than previously documented and constitute more than half of the mean household cost per episode. Detailed estimation of indirect costs has not previously been available for Bangladesh. An earlier study conducted in Germany reported 38% indirect cost for pneumonia management.38 This difference might be due to the dissimilarity in healthcare systems in LMICs compared with those in high-income countries, since continuous caregiving is required from the family for inpatient services, particularly for children, in resource-poor settings. These findings reveal and emphasise the extent to which severe pneumonia interrupts household income and productivity. Consistent with our findings, several other studies conducted in LMIC settings including Bangladesh reported indirect costs as a major cost contributor for other infectious diseases, including cholera (75%),16 malaria (72%–94%)39 40 and visceral leishmaniasis (53%).41
Costs varied between urban and rural areas, with household COI significantly greater when care was sought from urban-located hospitals. An earlier study reported higher treatment costs if care was sought from tertiary level hospitals compared with secondary level, and this finding was reaffirmed in Zhang et al’s review.12 27 This difference in costs might be due to the relative availability of secondary level public healthcare facilities in rural areas, which provide highly subsidised healthcare for pneumonia treatment-related costs, while tertiary hospitals have expensive resources.27 31
Findings reveal that households face a substantial economic burden to manage treatment cost. Although Bangladesh has introduced Haemophilus influenzae type b (Hib) in 2009 and 10-valent pneumococcal conjugate vaccine (PCV-10) vaccine in 2015 to prevent vaccine-preventable pneumonia, this study reveals the continuing considerable economic burden of child pneumonia despite successful (84%) immunisation coverage.42 Further research is needed to assess the contribution of vaccine-preventable pneumonia to the health and economic burden in Bangladesh. In the multivariate analysis, LoS, income quintile, type of facility and age of the child are identified as important predictors of household cost for severe childhood pneumonia management. Household costs in our study were most sensitive to hospital LoS. The average LoS was about 5 days, which is similar to the LoS described in studies conducted in low-resource settings such as Bangladesh, Kenya, Zambia, Jordan and Colombia.31 32 35 43 The negative association between age and COI may well reflect disease severity, with relatively more severe disease due to the immature immune status of young children <2 years old.14 With respect to the impact of income quintile, it is well reported that the wealthiest households consumed more healthcare services than the poorest counterparts in Bangladesh.14 15 41 44 The higher COI for wealthier households is likely to reflect affordability in contexts like Bangladesh, where households need to pay OOP fees for most healthcare services. In addition, the skew in our sample towards the upper income quintiles suggests that a large proportion of households in the lower income quintile do not seek care, likely due to economic burden. Strong policy initiatives are therefore essential to ensure the affordability and accessibility of healthcare services for childhood pneumonia, particularly for poorer groups, to reduce inequality.
Strengths and limitations
This study presents detailed household COI estimation including indirect costs and cost variation among socioeconomic groups and households’ coping strategies and determined the predictors of cost using primary data with a large sample size. Despite these strengths, this study has several limitations. First, indirect costs to households for severe pneumonia management might be underestimated because we valued unpaid time with the minimum wage rate. Second, since cost data were collected retrospectively, the study is subject to some recall bias because the interviewees needed to recall expenses. However, to reduce recall bias, they were asked to review prescriptions and receipts to complete the questionnaire. Finally, given the study perspective, we did not incorporate any costs borne by the provider, which might contribute to the underestimation of the total economic cost.
Severe pneumonia in young children is associated with substantial economic burden for households in Bangladesh. Costs varied significantly across facility type and location. In addition to ensuring Hib and PCV vaccine coverage, the findings highlight the potential efficiency and equity concerns to improve accessibility and affordability, particularly for poorer socioeconomic groups, to reduce household economic burden.
The clinical trial protocol (trial registration NCT02669654) has been approved by the ethical review committee of icddr,b (PR-14066). The economic evaluation protocol has been approved by Deakin University Human Research Ethics Committee (DUHREC) (2018-149).
The International Centre for Diarrhoeal Disease Research, Bangladesh is grateful to the governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. icddr,b acknowledges with gratitude the commitment of UBS Optimus Foundation and UNICEF Switzerland for funding the trial.
Contributors MS and LG conceptualised and designed the study. MS, NHA, ASGF, GJF, NG, MJC and TA designed the study, data collection instruments, supervised the data collection and drafted the initial manuscript. MS and NA supervised the data collection and analysed the data. LG supervised each stage of drafting the initial manuscript. NHA, NA, ASGF, GJF, NG, MJC, TA and LG critically reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Funding This work was jointly supported by UNICEF and UBS Optimus Foundation, Switzerland.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.